Cargando…
Correction: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy
Autores principales: | Hsu, Tsung-I, Chen, Ying-Jung, Hung, Chia-Yang, Wang, Yi-Chang, Lin, Sin-Jin, Su, Wu-Chou, Lai, Ming-Derg, Kim, Sang-Yong, Wang, Qiang, Qian, Keduo, Goto, Masuo, Zhao, Yu, Kashiwada, Yoshiki, Lee, Kuo-Hsiung, Chang, Wen-Chang, Hung, Jan-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849655/ https://www.ncbi.nlm.nih.gov/pubmed/31741716 http://dx.doi.org/10.18632/oncotarget.27297 |
Ejemplares similares
-
A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy
por: Hsu, Tsung-I, et al.
Publicado: (2015) -
Syk inhibitors in clinical development for hematological malignancies
por: Liu, Delong, et al.
Publicado: (2017) -
Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson’s Disease
por: Tsai, Chia-Wen, et al.
Publicado: (2018) -
Vous cherchez? (PRESSCUT-S-2006-023)
Publicado: (2006) -
Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan
por: Lai, Hsiang‐Lan, et al.
Publicado: (2019)